# A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets

> **NCT06680531** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Haiyan Pharmaceutical Technology Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Insomnia
- Central Nervous System

## Interventions

- **DRUG:** YZJ-1139 tablets
- **DRUG:** Escitalopram oxalate tablets
- **DRUG:** YZJ-1139 simulated tablets

## Key facts

- **NCT ID:** NCT06680531
- **Lead sponsor:** Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-31
- **Primary completion:** 2024-09-18
- **Final completion:** 2025-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06680531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06680531, "A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06680531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*